LMRI

+ Watchlist + Portfolio

Lumexa Imaging Holdings, Inc.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $10.32
52-Week Range: $6.45 – $19.45
Market Cap: $1.03B
P/E (TTM): —
EPS (TTM): -0.37
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.67
PEG Ratio: —
Return on Equity: —
Return on Assets: —
Gross Margin: 14.81%
Operating Margin: 3.20%
Profit Margin: -2.66%
Current Ratio: 1.44
Debt/Equity: 1.59
Total Debt: $975.35M
Free Cash Flow: —
Revenue Growth: 5.10%
Earnings Growth: —
Enterprise Value: $1.90B

LMRI Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Revenue	$935.92M	$948.87M	$1.02B
Cost of Revenue	$836.96M	$852.61M	$865.52M
Gross Profit	$98.97M	$96.26M	$157.56M
Selling, General & Admin	$55.16M	$70.36M	$90.45M
Operating Expenses	$111.80M	$112.53M	$130.83M
Operating Income	-$12.83M	-$16.26M	$26.73M
EBITDA	$94.51M	$113.96M	$141.71M
Pretax Income	-$119.25M	-$79.19M	-$32.22M
Income Tax	$2.98M	$14.91M	$14.88M
Net Income	-$122.23M	-$94.10M	-$47.10M
Diluted EPS	-1.76	-1.35	-0.66
Diluted Shares	69.41M	94.57M	70.98M

LMRI Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Cash & Equivalents	$20.19M	$26.13M	$58.83M
Receivables	$130.25M	$136.00M	$150.85M
Current Assets	$166.77M	$172.52M	$227.26M
Total Assets	$1.67B	$1.67B	$1.76B
Current Liabilities	$161.12M	$173.66M	$179.19M
Long-Term Debt	$1.18B	$1.19B	$819.03M
Total Debt	$1.30B	$1.31B	$962.50M
Total Liabilities	$1.47B	$1.51B	$1.18B
Retained Earnings	-$489.86M	-$583.96M	-$631.06M
Shareholders' Equity	$198.43M	$161.65M	$586.12M
Working Capital	$5.65M	-$1.14M	$48.07M
Net Debt	$1.18B	$1.17B	$774.91M

LMRI Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Operating Cash Flow	$37.51M	$40.73M	$17.07M
Capital Expenditure	-$24.01M	-$27.77M	-$23.48M
Free Cash Flow	$13.51M	$12.95M	-$6.40M
Depreciation & Amortisation	$72.07M	$57.13M	$55.39M
Stock-Based Compensation	$55.30M	$56.65M	$41.60M
Investing Cash Flow	-$29.66M	-$22.28M	-$20.96M
Financing Cash Flow	-$8.77M	-$12.50M	$36.58M
Share Repurchases	-$118.00K	$0.00	$0.00
Net Change in Cash	-$912.00K	$5.95M	$32.70M

LMRI Income statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$248.03M	$245.00M	$251.40M	$258.94M	$267.73M	$252.54M	$264.16M
Cost of Revenue	$226.46M	$208.40M	$212.26M	$219.24M	$225.62M	$217.75M	$225.28M
Gross Profit	$21.57M	$36.60M	$39.14M	$39.71M	$42.12M	$34.78M	$38.88M
Selling, General & Admin	$20.12M	$17.49M	$18.69M	$17.08M	$37.19M	$20.34M	$24.40M
Operating Expenses	$29.97M	$26.54M	$27.97M	$26.73M	$49.59M	$30.26M	$34.48M
Operating Income	-$8.40M	$10.06M	$11.17M	$12.97M	-$7.47M	$4.53M	$4.40M
EBITDA	$28.94M	$38.33M	$40.64M	$43.73M	$19.00M	$33.29M	$36.07M
Pretax Income	-$16.03M	-$4.31M	-$2.42M	-$237.00K	-$25.26M	$3.08M	$5.76M
Income Tax	$9.03M	$3.38M	$4.81M	$3.26M	$3.43M	$1.36M	$3.02M
Net Income	-$25.06M	-$7.69M	-$7.23M	-$3.50M	-$28.69M	$1.72M	$2.75M
Diluted EPS	—	-0.08	-0.08	—	-0.38	0.02	0.03
Diluted Shares	—	94.57M	94.57M	—	75.35M	95.98M	96.04M

LMRI Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$26.13M	$191.00K	—	—	$58.83M	$51.23M	—
Receivables	$136.00M	$148.65M	—	—	$150.85M	$154.13M	—
Current Assets	$172.52M	$165.92M	—	—	$227.26M	$221.89M	—
Total Assets	$1.67B	$1.69B	—	—	$1.76B	$1.76B	—
Current Liabilities	$173.66M	$179.99M	—	—	$179.19M	$157.93M	—
Long-Term Debt	$1.19B	$1.18B	—	—	$819.03M	$816.97M	—
Total Debt	$1.31B	$1.31B	—	—	$962.50M	$967.45M	—
Total Liabilities	$1.51B	$1.52B	—	—	$1.18B	$1.16B	—
Retained Earnings	-$583.96M	-$602.37M	—	—	-$631.06M	-$629.34M	—
Shareholders' Equity	$161.65M	$167.11M	—	—	$586.12M	$599.62M	—
Working Capital	-$1.14M	-$14.07M	—	—	$48.07M	$63.95M	—
Net Debt	$1.17B	$1.20B	—	—	$774.91M	$780.88M	—

LMRI Cash Flow statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$25.31M	-$13.96M	$2.07M	$11.86M	$17.10M	$2.93M	$32.80M
Capital Expenditure	-$5.87M	-$1.00M	-$4.60M	-$13.63M	-$4.25M	-$5.31M	-$10.27M
Free Cash Flow	$19.44M	-$14.96M	-$2.53M	-$1.77M	$12.85M	-$2.38M	$22.53M
Depreciation & Amortisation	$13.58M	$12.79M	$12.96M	$13.39M	$16.24M	$13.88M	$14.08M
Stock-Based Compensation	$14.04M	$6.37M	$8.35M	$8.31M	$18.57M	$12.27M	$12.74M
Investing Cash Flow	-$5.58M	-$720.00K	-$4.17M	-$13.67M	-$2.40M	-$5.27M	-$13.64M
Financing Cash Flow	-$4.93M	-$4.15M	-$462.00K	-$2.75M	$43.93M	-$5.26M	-$685.00K
Net Change in Cash	$14.80M	-$18.83M	-$2.56M	-$4.55M	$58.64M	-$7.60M	$18.48M

Market Snapshot

About

Lumexa Imaging Holdings, Inc. is a medical imaging company focused on developing and deploying advanced imaging technologies and solutions. The company provides services and equipment related to diagnostic imaging for healthcare providers. Lumexa operates in the healthcare technology sector, supporting radiology and imaging departments. The company aims to improve patient care through innovative imaging solutions.